Determining a potential for atypical clinical events when selecting clinical agents
AssigneeCerner Innovation, Inc.
InventorsMARK A. HOFFMAN, DAVID P. McCALLIE, JR.
Life of this patent
Estimating the term…
Loading patent…
AssigneeCerner Innovation, Inc.
InventorsMARK A. HOFFMAN, DAVID P. McCALLIE, JR.
Estimating the term…
Processes implemented within a computer system for preventing atypical clinical events resulting from administering unsuitable clinical agent(s) are provided. Initially, the processes involve receiving a list of possible clinical agent(s) that may be administered to a patient during a medical procedure. The processes further involve acquiring heredity data associated with the clinical agent(s) by comparing the clinical agent(s) against a data set or the patient's medical records. If the heredity data indicates that the patient scheduled to receive the clinical agent(s) would experience atypical clinical events as a potential outcome, a warning that the clinical agent(s) should not be administered by a clinician is presented or reference information about the atypical clinical event is output. Accordingly, a preemptive determination of the atypical clinical events potentially occurring upon administering the clinical agent(s) to the patient is made.
One or more computer storage media having computer-executable instructions embodied thereon that, when executed, perform a method that employs hereditary data to aid in selection of clinical agents that are least likely to adversely interact with a person, the method comprising the steps of:
Dependencies are inferred from the claim text.